Actual Medicinal Product (AMP) Zomorph 30mg modified-release capsules (Ethypharm UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products MXL 30mg prolonged release capsules (Napp Pharmaceuticals Limited) and Zomorph 30mg capsules (Ethypharm UK Ltd).
- Generic
- Morphine
- Formulation
- Morphine 30mg modified-release capsules
-
Morphine
-
Morphine 30mg modified-release capsules
-
Zomorph 30mg modified-release capsules (Ethypharm UK Ltd)
-
-
Morphine 10mg tablets
Morphine 200mg capsules